In this week’s edition of InnovationRx, we look at a ‘holy grail’ pill for sleep apnea, Pomelo Care’s expansion, Nvidia and Lilly’s $1 billion AI venture, and more.
Nicolas Petrovic, who led the London-Paris-Brussels train systems, will oversee the company’s expanding Florida operations and the first U.S. high-speed railway.
Here are strategies to ensure employees at every level get the most from AI.
San Francisco-based Checkr has seen its revenues jump 14% to $800 million as companies try to spot a flood of AI-generated CVs and faked financial documents.
This week’s Current Climate newsletter also looks at the AI boom’s water problem and stabilized funding for the California High-Speed Rail project.
B.Grimm Power—controlled by Thai billionaire Harald Link—has bought a stake in U.S.-based hydropower operator New England Reliable Hydropower Holdings for 7.24 billion baht ($230 million) amid the group’s drive to expand its overseas renewable energy p…
Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to treat it, is preparing to file for FDA approval.
Forbes’ eighth annual AI 50 list, featuring the most prominent AI startups, is accepting submissions until February 6, 2026.
Viral AI images after the MInneapolis ICE shooting show how easily fabricated faces can masquerade as evidence —and why that confusion is dangerous.
In this week’s edition of The Prototype, we look at building a virtual fusion power plant, a major quantum breakthrough, AI for drug discovery and more.